Literature DB >> 6129474

Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies.

R Gokal, J M Ramos, D M Francis, R E Ferner, T H Goodship, G Proud, A J Bint, M K Ward, D N Kerr.   

Abstract

During a three year period, 1979-81, 82 patients were treated by continuous ambulatory peritoneal dialysis (CAPD). The incidence of peritonitis was reduced significantly during the three years from one episode per 20 patient-weeks to one episode every 37 patient-weeks. 83% of the 136 episodes of peritonitis were treated successfully by antibiotic therapy alone. 62% of the total episodes were managed successfully with intraperitoneal cefuroxime. in 13 (16%) patients, CAPD failed because of peritonitis. Hospital admission for peritonitis has been reduced to a mean of 4.3 days per patient per year of CAPD. Fron January to September, 1982, Clostridium-difficile colitis developed in 13 patients. This complication was associated with considerable mortality and morbidity and has prompted a change in antibiotic policy. Patients with peritonitis are now given intraperitoneal netilmicin and intravenous vancomycin. Peritonitis remains the main complication of CAPD, but can be minimised by development of adequate facilities for performing CAPD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129474     DOI: 10.1016/s0140-6736(82)91282-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  The ultrastructure of human abdominal mesothelium.

Authors:  N J Slater; A T Raftery; G H Cope
Journal:  J Anat       Date:  1989-12       Impact factor: 2.610

2.  Continuous ambulatory peritoneal dialysis after the honeymoon: review of experience in Newcastle 1979-84.

Authors:  A Heaton; R S Rodger; L Sellars; T H Goodship; K Fletcher; N Nikolakakis; M K Ward; R Wilkinson; D N Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

3.  Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis.

Authors:  J L Schmit; L Hary; P Bou; H Renaud; P F Westeel; M Andrejak; A Fournier
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Diarrhoea due to Clostridium difficile associated with antibiotic treatment in patients receiving dialysis: the role of cross infection.

Authors:  A D Cumming; B J Thomson; J Sharp; I R Poxton; A Fraser
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

5.  Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

6.  Improved method for recovery of peritonitis-causing microorganisms from peritoneal dialysate.

Authors:  S Ryan; S Fessia
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

Authors:  H A Verbrugh; W F Keane; W E Conroy; P K Peterson
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

8.  Effect of dialysate fluids on phagocytosis and killing by normal neutrophils.

Authors:  D M Harvey; K J Sheppard; A G Morgan; J Fletcher
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Factors affecting development of peritonitis in continuous ambulatory peritoneal dialysis.

Authors:  T H Goodship; A Heaton; R S Rodger; M K Ward; R Wilkinson; D N Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-01

10.  Peritonitis prevented in continuous ambulatory peritoneal dialysis by using the Hong Kong connection.

Authors:  R D Clark
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.